ATE195873T1 - Durch glykosylierung vermittelte hemmung des faktors x - Google Patents

Durch glykosylierung vermittelte hemmung des faktors x

Info

Publication number
ATE195873T1
ATE195873T1 AT93908307T AT93908307T ATE195873T1 AT E195873 T1 ATE195873 T1 AT E195873T1 AT 93908307 T AT93908307 T AT 93908307T AT 93908307 T AT93908307 T AT 93908307T AT E195873 T1 ATE195873 T1 AT E195873T1
Authority
AT
Austria
Prior art keywords
factor
reagents
conversion
glycosylation
mediated
Prior art date
Application number
AT93908307T
Other languages
English (en)
Inventor
Uma Sinha
David L Wolf
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Application granted granted Critical
Publication of ATE195873T1 publication Critical patent/ATE195873T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT93908307T 1992-03-20 1993-03-11 Durch glykosylierung vermittelte hemmung des faktors x ATE195873T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85410992A 1992-03-20 1992-03-20
PCT/US1993/002203 WO1993018782A1 (en) 1992-03-20 1993-03-11 Glycosylation-mediated inhibition of factor x

Publications (1)

Publication Number Publication Date
ATE195873T1 true ATE195873T1 (de) 2000-09-15

Family

ID=25317754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908307T ATE195873T1 (de) 1992-03-20 1993-03-11 Durch glykosylierung vermittelte hemmung des faktors x

Country Status (9)

Country Link
US (3) US6117836A (de)
EP (1) EP0631501B1 (de)
JP (1) JPH07507769A (de)
AT (1) ATE195873T1 (de)
AU (1) AU681074B2 (de)
CA (1) CA2132518A1 (de)
DE (1) DE69329333D1 (de)
IL (1) IL105064A (de)
WO (1) WO1993018782A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
ATE210452T1 (de) * 1992-10-02 2001-12-15 Alberta Res Council Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
SE507737C2 (sv) * 1996-11-08 1998-07-06 Golvabia Ab Anordning för sammanfogning av golvbeläggningsmaterial
HUE052423T2 (hu) 2007-09-28 2021-04-28 Alexion Pharma Inc Az XA faktor inhibitorok antidótumai és ezek alkalmazási módszerei
DK2202306T3 (da) * 2007-10-09 2013-01-21 Chemo Sero Therapeut Res Inst Rekombinant faktor x uden glycosylering og fremgangsmåde til fremstilling deraf
WO2010117729A1 (en) 2009-03-30 2010-10-14 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
KR101673195B1 (ko) * 2013-11-18 2016-11-07 한국생명공학연구원 구멍장이 버섯 유래의 시알산 결합 특이적인 재조합 렉틴

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
US4668621A (en) * 1985-04-22 1987-05-26 Wake Forest University Detecting blood clotting factors with immobilized fibrinogen and labeled fibrinogen
US5066480A (en) * 1988-04-11 1991-11-19 E. R. Squibb & Sons, Inc. Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5278144A (en) * 1990-09-04 1994-01-11 Cor Therapeutics, Inc. Antithrombosis agents
EP0575557A1 (de) * 1991-03-11 1993-12-29 New England Medical Center Verfahren zur hemmung von padgem-vermittelter interaktionen unter verwendung von einer 2,6-sialinsäure
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide

Also Published As

Publication number Publication date
AU3917793A (en) 1993-10-21
EP0631501A4 (de) 1995-12-27
WO1993018782A1 (en) 1993-09-30
DE69329333D1 (de) 2000-10-05
IL105064A0 (en) 1993-07-08
CA2132518A1 (en) 1993-09-30
US20030207796A1 (en) 2003-11-06
EP0631501A1 (de) 1995-01-04
AU681074B2 (en) 1997-08-21
US5798332A (en) 1998-08-25
JPH07507769A (ja) 1995-08-31
IL105064A (en) 1997-04-15
US6117836A (en) 2000-09-12
EP0631501B1 (de) 2000-08-30

Similar Documents

Publication Publication Date Title
Yamamoto et al. The structure of carbohydrate unit B of porcine thyroglobulin
Turner et al. Involvement of a carbohydrate group in the active site for surface guided reassociation of animal cells
Yamashita et al. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin.
ATE195873T1 (de) Durch glykosylierung vermittelte hemmung des faktors x
ES8604986A1 (es) Procedimiento para la preparacion de derivado de esfingosina.
HK1016213A1 (en) Il-6 activity inhibitor
ATE338762T1 (de) Zusammensetzungen und methoden für die verknüpfung von endothelzellen
ATE261932T1 (de) Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
Oates et al. Further investigations into the structure of human gastric mucin: The structural configuration of the oligosaccharide chains
MIZUOCHI et al. New evidence of the substrate specificity of endo-β-N-acetylglucosaminidase D
Scully et al. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II
FR2570081B1 (fr) Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
GR852029B (de)
EP0429542A4 (en) Leukocyte adhesion inhibitor
Sasaki et al. Structure of linkage region between glycerol teichoic acid and peptidoglycan in Bacillus cereus AHU 1030 cell walls
Mascellani et al. Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins
Codington et al. Variations in the sialic acid compositions in glycoproteins of mouse ascites tumor cell surfaces
ZA931723B (en) Method for producing carbohydrates
Basten et al. Synthesis of a dermatan sulphate-like hexasaccharide with a “non-glycosamino” glycan structure
Beltrame et al. Kinetics of enzymic hydrolysis of malto-oligosaccharides: A comparison with acid hydrolysis
Masuda et al. Electrophoresis of glycosaminoglycans of the human gastric mucosa
Fukamachi et al. The synthesis of ribosomal-type RNA by isolated rat liver mitochondria
Yosizawa Enzymic degradation of ω-heparin (Whale heparin)
Tamura Recent aspects of proteoglycan syntheses
Iwasaki et al. Structural studies on the amino‐acid‐linked teichuronic acid of Bacillus subtilis AHU 1219 cell walls